TGFB1 and neoplasm: Platelet aggregation-inducing factor, podoplanin, frequently upregulated on tumour cell surfaces, was found to not only trigger the formation of tumor–platelet crosstalk but also facilitate EMT by inducing TGF-β release from platelets [35].